0001385508-19-000006.txt : 20190104 0001385508-19-000006.hdr.sgml : 20190104 20190104171818 ACCESSION NUMBER: 0001385508-19-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190103 FILED AS OF DATE: 20190104 DATE AS OF CHANGE: 20190104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Toole David D CENTRAL INDEX KEY: 0001491140 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38193 FILM NUMBER: 19511118 MAIL ADDRESS: STREET 1: 1640 MARENGO STREET CITY: LOS ANGELES STATE: CA ZIP: 90033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OPIANT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001385508 STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 SANTA MONICA BOULEVARD STREET 2: SUITE 500 CITY: SANTA MONICA STATE: CA ZIP: 90401 BUSINESS PHONE: (310) 598-5410 MAIL ADDRESS: STREET 1: 201 SANTA MONICA BOULEVARD STREET 2: SUITE 500 CITY: SANTA MONICA STATE: CA ZIP: 90401 FORMER COMPANY: FORMER CONFORMED NAME: Lightlake Therapeutics Inc. DATE OF NAME CHANGE: 20091009 FORMER COMPANY: FORMER CONFORMED NAME: Madrona Ventures, Inc. DATE OF NAME CHANGE: 20070108 4 1 wf-form4_154664028137802.xml FORM 4 X0306 4 2019-01-03 0 0001385508 OPIANT PHARMACEUTICALS, INC. OPNT 0001491140 O'Toole David D C/O OPIANT PHARMACEUTICALS, INC. 201 SANTA MONICA BOULEVARD, SUITE 500 SANTA MONICA CA 90401 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 13.61 2019-01-03 4 A 0 33000 0 A 2029-01-02 Common Stock 33000.0 33000 D On January 3, 2019, the reporting person was granted an option to purchase 33,000 shares of common stock. The option vests as follows: 1/48 of the options become exercisable on the first monthly anniversary of the vesting commencement date, and 1/48 of the options become exercisable on such date every month thereafter through the fourth anniversary of the Grant Date. /s/ David D. O'Toole 2019-01-04